Sermorelin Acetate
Clinical evidence — Human trial data existsWhat it is
A growth-hormone-releasing hormone analogue that was previously an approved diagnostic/therapeutic agent.
Sermorelin is a GHRH analogue that was previously an approved diagnostic/therapeutic agent, promoting a natural pulsatile GH release, typically dosed at night.
Research context
Studied in relation to:
- GH-axis research/diagnostics
Points in its favour in the literature:
- Historically approved, human data exists
- Physiological pulsatile action
Caveats and unknowns:
- Original product withdrawn in some markets
- Research-grade differs from licensed drug
- Prohibited in sport
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature. Usually before sleep.
Reported half-lifeshort (~10–20 min)
Published clinical / research context (not instructions)Reported research ~100–300 mcg before sleep.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 5 mg vial + 2 mL → 2.5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 5mg | SMO5 |
| 10mg | SMO10 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.